Cite

HARVARD Citation

    Denneny, E. et al. (n.d.). P55 Bleeding risk in patients with idiopathic pulmonary fibrosis (IPF) on nintedanib and con-current anticoagulation or antiplatelet therapy. Thorax. p. A119. [Online]. 
  
Back to record